Clostridium difficile infection

Curr Probl Surg. 2013 Jul;50(7):302-37. doi: 10.1067/j.cpsurg.2013.02.004.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Anion Exchange Resins / therapeutic use
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / therapeutic use*
  • Bacterial Proteins / analysis
  • Bacterial Proteins / immunology
  • Bacterial Toxins / analysis
  • Bacterial Toxins / immunology
  • Bacterial Vaccines / administration & dosage
  • Canada / epidemiology
  • Clostridium Infections* / diagnosis
  • Clostridium Infections* / epidemiology
  • Clostridium Infections* / therapy
  • Clostridium difficile* / isolation & purification
  • Clostridium difficile* / pathogenicity
  • Colectomy
  • Colonoscopy
  • Diagnosis, Differential
  • Diarrhea / microbiology
  • Disease Outbreaks
  • Disease Progression
  • Early Diagnosis
  • Enterocolitis, Pseudomembranous* / diagnosis
  • Enterocolitis, Pseudomembranous* / epidemiology
  • Enterocolitis, Pseudomembranous* / therapy
  • Enterotoxins / analysis
  • Enterotoxins / immunology
  • Europe / epidemiology
  • Feces / microbiology
  • Humans
  • Ileostomy
  • Immunoglobulins, Intravenous / therapeutic use
  • Intestinal Pseudo-Obstruction / microbiology
  • Practice Guidelines as Topic
  • Prevalence
  • Probiotics / therapeutic use
  • Risk Factors
  • Treatment Outcome
  • United States / epidemiology

Substances

  • Anion Exchange Resins
  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Bacterial Toxins
  • Bacterial Vaccines
  • Enterotoxins
  • Immunoglobulins, Intravenous
  • tcdA protein, Clostridium difficile
  • toxB protein, Clostridium difficile